miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. (Q39459142)

12 September 2017

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. (English)

1 reference

12 September 2017

multiple drug resistance

1 reference

Wei Zhu

1

1 reference

12 September 2017

Huaguo Xu

2

1 reference

12 September 2017

DanXia Zhu

3

1 reference

12 September 2017

Hui Zhi

4

1 reference

12 September 2017

Tongshan Wang

5

1 reference

12 September 2017

Jian Wang

6

1 reference

12 September 2017

Binghua Jiang

7

1 reference

12 September 2017

Yongqian Shu

8

1 reference

12 September 2017

Ping Liu

9

1 reference

12 September 2017

language of work or name

1 reference

13 October 2011

1 reference

Cancer Chemotherapy and Pharmacology

12 September 2017

1 reference

12 September 2017

69

1 reference

12 September 2017

3

1 reference

12 September 2017

723-731

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-011-1752-3

12 September 2017

0 references

cites work

Targeting multidrug resistance in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Epigenetics as a mechanism driving polygenic clinical drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Role of microRNA in anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

MicroRNA and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Implication of microRNAs in drug resistance for designing novel cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemothera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Targeting Bcl-2 and Bcl-X with nonpeptidic small-molecule antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

Thymineless death in colon carcinoma cells is mediated via fas signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1752-3

10.1007/S00280-011-1752-3

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference